• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Aslan Pharmaceuticals Ltd ADR (NQ: ASLN )

    0.4570 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Apr 29, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1
    Open 0.4570
    Bid (Size) 0.4580 (1)
    Ask (Size) 0.4831 (6)
    Prev. Close 0.4570
    Today's Range 0.4570 - 0.4570
    52wk Range 0.3920 - 4.575
    Shares Outstanding 402,116,835
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    ASLAN Pharmaceuticals Announces Late Breaking Abstract on Eblasakimab in COPD Accepted for Presentation at the American Thoracic Society International Conference
    From ASLAN PHARMACEUTICALS LIMITED
    Via GlobeNewswire

    Performance

    YTD
    -16.91%
    -16.91%
    1 Month
    -23.90%
    -23.90%
    3 Month
    -30.76%
    -30.76%
    6 Month
    -59.91%
    -59.91%
    1 Year
    -88.58%
    -88.58%

    More News

    Read More
    ASLAN Pharmaceuticals Announces Positive Interim Results From Phase 2 Study of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients
    From ASLAN PHARMACEUTICALS LIMITED
    Via GlobeNewswire
    ASLAN Pharmaceuticals Announces Receipt of Nasdaq Notice
    From ASLAN PHARMACEUTICALS LIMITED
    Via GlobeNewswire
    ASLN Stock Earnings: ASLAN Pharma Misses EPS for Q4 2023
    Via InvestorPlace
    ASLAN Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
    From ASLAN PHARMACEUTICALS LIMITED
    Via GlobeNewswire
    Aslan Pharmaceuticals to Present at the 2nd Annual H.C. Wainwright Autoimmune and Inflammatory Disease Virtual Conference: Skin Diseases, Conditions and Disorders
    From ASLAN PHARMACEUTICALS LIMITED
    Via GlobeNewswire
    Week In Review: Under Pressure From US Congress, WuXi AppTec Resigns From BIO
    Via Talk Markets
    ASLAN Pharmaceuticals Announces $5 Million Registered Direct Offering
    From ASLAN PHARMACEUTICALS LIMITED
    Via GlobeNewswire
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    ASLAN Pharmaceuticals Provides TREK-DX Study Update and Highlights Potential of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients
    From ASLAN PHARMACEUTICALS LIMITED
    Via GlobeNewswire
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    ASLAN Pharmaceuticals Announces New Translational Data on Eblasakimab in COPD and Appoints Leading Respiratory Experts as Scientific Advisors
    From ASLAN PHARMACEUTICALS LIMITED
    Via GlobeNewswire
    ASLAN Pharmaceuticals Receives Favorable Opinion From the European Patent Office on Composition of Matter Patent Application for Farudodstat
    From ASLAN PHARMACEUTICALS LIMITED
    Via GlobeNewswire
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    ASLAN Pharmaceuticals Announces Receipt of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
    From ASLAN PHARMACEUTICALS LIMITED
    Via GlobeNewswire
    ASLAN Pharmaceuticals Announces Participation in January Investor Conferences
    From ASLAN PHARMACEUTICALS LIMITED
    Via GlobeNewswire
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    ASLAN Pharmaceuticals Provides Year-End Update on Its Eblasakimab and Farudodstat Programs
    From ASLAN PHARMACEUTICALS LIMITED
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.